Kirk A. Frey
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Neuroscience BiologyGoogle:
"Kirk Frey"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kanel P, Müller MLTM, van der Zee S, et al. (2020) Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych190701 |
| Kramer V, Brooks AF, Haeger A, et al. (2020) Evaluation of [F]N-methyl-lansoprazole as a tau PET imaging agent in first-in-human studies. Acs Chemical Neuroscience |
| Viglianti BL, Wale DJ, Ma T, et al. (2019) Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 112: 108628 |
| Bohnen NI, Kanel P, Zhou Z, et al. (2019) Cholinergic system changes of falls and freezing of gait in Parkinson disease. Annals of Neurology |
| Albin RL, Bohnen NI, Muller ML, et al. (2018) Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [ F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study. The Journal of Comparative Neurology |
| Nejad-Davarani S, Koeppe RA, Albin RL, et al. (2018) Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [F]-FEOBV. Molecular Psychiatry |
| Viglianti BL, Wale DJ, Wong KK, et al. (2018) Effects of Tumor Burden on Reference Tissue Standardized Uptake for PET Imaging: Modification of PERCIST Criteria. Radiology. 171356 |
| Subramaniam RM, Frey KA, Hunt CH, et al. (2017) ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders. Clinical Nuclear Medicine |
| Salloway S, Gamez JE, Singh U, et al. (2017) Performance of [(18)F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 9: 25-34 |
| Kong FM, Ten Haken RK, Schipper M, et al. (2017) Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial. Jama Oncology |